IGEA Pharma has announced that LMH – an industrial holding company – has completed the due diligence process for a euro 6.000.000 committment to fund the swiss CBD extraction facility

Hoofddorp, the Netherlands, 13th July 2022. Today IGEA Pharma N.V. (SIX: IGPH) has announced that LMH Holding has completed the due diligence process on the Company in relation to its Euro 6.0 million commitment to fund the GMP-Pharma CBD extraction facility owned through its joint-venture Blue Sky Swisse S.A.

Read More

IGEA pharma non-executive board members resigned after completion of the first post-combination phase. New members to be nominated

Hoofddorp, the Netherlands, 1February 2022. Today the Board of Directors of IGEA Pharma N.V. (SIX: IGPH) has acknowledged the resignation of Mrs Giovanna Puppo, Mr Raffaele Bertoni, Mr Lieven Baten and Mr Massimiliano Colella as members of the Board of Directors. The resignation is effective as of 31 January 2022 and is motivated by personal reasons.

Read More